Clinical Study

Inflammation, Diabetes, and Chronic Kidney Disease: Role of Aerobic Capacity

Table 1

Clinical variables and laboratorial characteristics of patients.

Patients39
 Hemodialysis17
 Predialysis22

Age (years)
Kidney disease etiology
 Hypertension 16
 Diabetes11
 Glomerulopathies7
 Others5
BMI (Kg/m2)
Central SBP (mm Hg)
Central DBP (mm Hg)
Central PP (mm Hg)
Pulse wave velocity (m/s)
Augmentation index (%)
VO2max (mL/kg/min)
CA-IMT L—m (mm)
CA-IMT L—mx (mm)
CA-IMT R—m (mm)
CA-IMT R—mx (mm)
Presence of atherosclerotic plaque (%)41%
Creatinine (mg/dL)
Clearance of creatinine (mL/min)
Hemoglobin (g/dL)
Calcium (mg/dL)
Phosphorus (mg/dL)
CRP (mg/dL)
PTH (pg/mL)
Albumin (g/dL)
Ferritin (g/dL)
Transferrin saturation (%)

BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; PP: pulse pressure; PWV: pulse wave velocity; AIx: augmentation index; CA-IMT L—m: mean of left carotid intima-media thickness; CA-IMT L—mx: maximal of left carotid intima-media thickness; CA-IMT R—m: mean of right carotid intima-media thickness; CA-IMT R—mx: maximal of right carotid intima-media thickness; CRP: C-reactive protein; PTH: parathyroid hormone.